经尿道精囊镜技术在血精症患者诊治中的临床价值探析  

Clinical value of transurethral seminal vesiculoscopy in the diagnosis and treatment of patients with hematospermia

作　　者：孙伟[1] 张鑫 潘森[1] SUN Wei;ZHANG Xin;PAN Sen(Department of Urology,Fuling Central Hospital,Chongqing 408000,China)

机构地区：[1]重庆市涪陵中心医院泌尿外科,重庆408000

出　　处：《中国性科学》2019年第5期30-33,共4页Chinese Journal of Human Sexuality

基　　金：重庆市涪陵区科技计划项目(FLKW2017ABB1044);重庆市涪陵区应用技术研究与开发资金项目(FLKJ2014ABB2109)

摘　　要：目的探讨经尿道精囊镜手术治疗血精症患者的临床效果及安全性,以及对患者性生活质量的影响。方法选择2014年2月至2017年1月重庆市涪陵中心医院诊治的经单纯药物治疗反复发作的60例血精患者为研究对象,根据医生建议、患者自愿的原则,将其分为观察组和对照组。观察组28例患者,采用经尿道精囊镜手术治疗;对照组32例患者,采用综合保守治疗。两组患者分别于治疗前、治疗完成3个月后,取精液于精液镜下计数红细胞和白细胞数并进行比较。完成治疗后3个月随访,根据患者临床症状改变、精液质量检查和B超检查结果,判断两组患者的临床治疗效果。比较两组患者治疗前、治疗后3个月勃起功能(IIEF-5)、射精功能(CIPE)评分。结果完成治疗3个月后,观察组患者精液红细胞计数和白细胞计数均明显低于对照组患者(均P<0.05)。完成治疗后3个月随访评价临床疗效,观察组患者临床总有效率明显高于对照组患者(P<0.05)。完成治疗3个月后,观察组患者IIEF-5评分、CIPE评分均明显高于对照组患者(均P<0.05)。结论经尿道精囊镜技术治疗血精症患者临床效果明显优于综合保守治疗,可以有效消除患者血精临床症状,提高患者性生活质量。ObjectiveTo investigate the clinical efficacy and safety of transurethral seminal vesiculoscopy surgery for patients with hematospermia, and the impact on quality of sexual life of patients. Methods60 patients with recurrent hematospermia treated by simple drug treatment in Fuling Central Hospital from February 2014 to January 2017 were selected and divided into the observation group (28 cases) and control group (32 cases) according to doctor′s suggestion and the principle of voluntary. The observation group received transurethral seminal vesiculoscopy surgery while the control group received comprehensive conservative treatment. The number of red blood cells and leukocytes was counted and compared between before treatment and 3 months after treatment. All the patients were followed up for 3 months after completion of the treatment, the clinical treatment effect of the two groups was judged and compared according to the changes in the clinical symptoms, the quality of semen and the results of B-ultrasound examination. The scores of erectile function (IIEF-5) and ejaculatory function (CIPE) were compared between the two groups before treatment and 3 months after treatment. ResultsAt 3 months after treatment, the red blood cell count and leukocyte count in the semen in the observation group were significantly lower than those in the control group (all P<0.05). Within the 3 months′ follow-up, the clinical efficacy was evaluated. The total effective rate in the observation group was significantly higher than that in the control group (P<0.05). The IIEF-5 score and CIPE score in the observation group were significantly higher than those in the control group (all P<0.05). ConclusionsTransurethral seminal vesiculoscopy is of better effect than conservative treatment in the treatment of hemospermia patients, which can effectively eliminate the clinical symptoms of patients and improve the quality of sexual life of patients.

关 键 词：血精症 经尿道精囊镜技术 临床疗效 性生活质量 临床价值 

分 类 号：R697[医药卫生—泌尿科学]